{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:00:24Z","timestamp":1794654024529,"version":"4.9.1"},"reference-count":37,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153152"],"award-info":[{"award-number":["R01AI153152"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Emory\/Georgia TB Research Advancement Center","award":["P30AAI168386"],"award-info":[{"award-number":["P30AAI168386"]}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW007124"],"award-info":[{"award-number":["D43TW007124"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW009337"],"award-info":[{"award-number":["D43TW009337"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["R21TW011157"],"award-info":[{"award-number":["R21TW011157"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,4,7]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tuberculosis (TB) remains a critical global public health challenge, and there is an urgent need to improve the diagnosis and management of post-TB lung disease (PTLD). We aimed to compare end of treatment prevalence of PTLD among participants with and without drug-resistant TB and to evaluate the association between plasma cytokines and matrix metalloproteinases with lung damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study among individuals with microbial cure status for drug-susceptible or multidrug-resistant pulmonary TB in Tbilisi, Georgia during 2020\u20132021. Eligible participants were \u226516 years without prior TB treatment history, microbiologically confirmed disease at baseline and who had a favourable treatment outcome (cured or completed treatment). The study outcome was the presence of PTLD defined as abnormalities on either chest CT, spirometry or Saint George\u2019s Respiratory Questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 123 participants, the prevalence of PTLD was 74% (n=91) with 53 participants meeting one criteria, 27 two criteria and 11 all three criteria. The prevalence of impaired respiratory health (47%) and lung damage on imaging (46%) was higher than abnormal lung function (21%). PTLD was not associated with drug resistance (adjusted OR 0.91, 95% CI 0.42 to 1.99). Persistent cavitary disease at the end of treatment was associated with higher matrix metalloproteinase 8 and lower matrix metalloproteinase 2, interleukin-17A and interleukin-1\u00df.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Using comprehensive criteria, we found nearly three in four individuals with microbial cure status for TB disease had prevalent PTLD regardless of drug resistance status. Persistent cavitary disease was associated with serum markers of inflammation and lung tissue remodelling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2024-222350","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T19:35:13Z","timestamp":1746646513000},"page":"170-178","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis"],"prefix":"10.1136","volume":"81","author":[{"given":"Russell R","family":"Kempker","sequence":"first","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-0348","authenticated-orcid":false,"given":"Argita D","family":"Salindri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"},{"name":"Department of Population Health Sciences, Georgia State University School of Public Health, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teona","family":"Avaliani","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardy","family":"Kornfeld","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C","family":"Auld","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA"},{"name":"Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA"},{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Jakobia","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L","family":"Day","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center, Emory University, Atlanta, Georgia, USA"},{"name":"Department of Microbiology and Immunobiology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijita","family":"Subuddhi","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center, Emory University, Atlanta, Georgia, USA"},{"name":"Department of Microbiology and Immunobiology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista N","family":"Krish","sequence":"additional","affiliation":[{"name":"Emory Vaccine Center, Emory University, Atlanta, Georgia, USA"},{"name":"Department of Microbiology and Immunobiology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergo","family":"Vashakidze","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"},{"name":"The University of Georgia, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Avaliani","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"},{"name":"European University, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Goginashvili","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Bryan","sequence":"additional","affiliation":[{"name":"Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bernheim","sequence":"additional","affiliation":[{"name":"Main Street Radiology, Queens, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Kipiani","sequence":"additional","affiliation":[{"name":"National Center For Tuberculosis And Lung Diseases, Tbilisi, Georgia"},{"name":"The University of Georgia, Tbilisi, Georgia"},{"name":"David Tvildiani Medical University, Tbilisi, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Magee","sequence":"additional","affiliation":[{"name":"Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA"},{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"2026012006550571000_81.2.170.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2949"},{"key":"2026012006550571000_81.2.170.2","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-10-259","article-title":"Pulmonary impairment after tuberculosis and its contribution to TB burden","volume":"10","author":"Pasipanodya","year":"2010","journal-title":"BMC Public Health"},{"key":"2026012006550571000_81.2.170.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-020-01368-4","article-title":"Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis","volume":"21","author":"Auld","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2026012006550571000_81.2.170.4","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0425"},{"key":"2026012006550571000_81.2.170.5","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0278"},{"key":"2026012006550571000_81.2.170.6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2213-2600(20)30039-4","article-title":"Post-tuberculosis mortality and morbidity: valuing the hidden epidemic","volume":"8","author":"Quaife","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026012006550571000_81.2.170.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68435-3"},{"key":"2026012006550571000_81.2.170.8","first-page":"625","article-title":"Obstructive airway disease in patients with treated pulmonary tuberculosis","volume":"103","author":"Snider","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"2026012006550571000_81.2.170.9","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.20.0067"},{"key":"2026012006550571000_81.2.170.10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012006550571000_81.2.170.11","unstructured":"Global tuberculosis report 2023. Geneva World Health Organization; 2023."},{"key":"2026012006550571000_81.2.170.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00015411"},{"key":"2026012006550571000_81.2.170.13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001847","article-title":"Tuberculosis immunopathology: the neglected role of extracellular matrix destruction","volume":"3","author":"Elkington","year":"2011","journal-title":"Sci Transl Med"},{"key":"2026012006550571000_81.2.170.14","unstructured":"WorldHealthOrganization . Definitions and Reporting Framework for Tuberculosis-2013 Revision. Geneva: World Health Organization, 2013."},{"key":"2026012006550571000_81.2.170.15","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0468"},{"key":"2026012006550571000_81.2.170.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.04.033"},{"key":"2026012006550571000_81.2.170.17","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136242"},{"key":"2026012006550571000_81.2.170.18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"2026012006550571000_81.2.170.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202301-0106PP"},{"key":"2026012006550571000_81.2.170.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.02.039"},{"key":"2026012006550571000_81.2.170.21","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-0702"},{"key":"2026012006550571000_81.2.170.22","unstructured":"Jones P , St. George\u2019s, University of London . ST george\u2019s respiratory questionnaire for copd patients (sgrq-c) manual. division of clinical science. version no. 1.3. 2016."},{"key":"2026012006550571000_81.2.170.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2026012006550571000_81.2.170.24","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199901000-00005"},{"key":"2026012006550571000_81.2.170.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31644-1"},{"key":"2026012006550571000_81.2.170.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119430"},{"key":"2026012006550571000_81.2.170.27","first-page":"767","article-title":"Residual lung damage after completion of treatment for multidrug-resistant tuberculosis","volume":"8","author":"de Valli\u00e8re","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012006550571000_81.2.170.28","first-page":"206","article-title":"Post treatment sequelae of multi-drug resistant tuberculosis patients","volume":"56","author":"Singla","year":"2009","journal-title":"Indian J Tuberc"},{"key":"2026012006550571000_81.2.170.29","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00026-2017","article-title":"Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis","volume":"3","author":"Byrne","year":"2017","journal-title":"ERJ Open Res"},{"key":"2026012006550571000_81.2.170.30","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa139"},{"key":"2026012006550571000_81.2.170.31","doi-asserted-by":"crossref","first-page":"e1679","DOI":"10.1016\/S2214-109X(21)00367-3","article-title":"Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae","volume":"9","author":"Menzies","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2026012006550571000_81.2.170.32","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2026012006550571000_81.2.170.33","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac160"},{"key":"2026012006550571000_81.2.170.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004917","article-title":"Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis","volume":"11","author":"Ong","year":"2015","journal-title":"PLoS Pathog"},{"key":"2026012006550571000_81.2.170.35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903332"},{"key":"2026012006550571000_81.2.170.36","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","volume":"9","author":"Wallis","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026012006550571000_81.2.170.37","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00213202"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2024-222350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:55:31Z","timestamp":1768920931000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2024-222350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,15]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/thorax-2024-222350"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2024-222350","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}